Search

Branchio Oto Renal syndrome

Branchio Oto Renal Syndrome (BOR) is an autosomal dominant disorder with branchial, otologic and renal manifestations. The presence of clinical signs varies among and within affected families. Three causative genes for BOR syndrome have been reported thus far: EYA1, SIX1...

Surgical management of sleep disordered breathing

Snoring and sleep-disordered breathing are often described as multi-level problems, and different surgical procedures are required to treat the various sites of airway narrowing and/or collapse. Jonathan Hobson gives us an eloquent run-through the various options available to the ENT...

Vocal cord paralysis: an update

The management of unilateral vocal cord paralysis has changed in the last few years: this has largely come about as a result of improvements in technology, meaning that medialisations are quicker and easier to perform than previously. This article will...

What’s new in hearing aid technology? Requisites for successful implementation of eHealth in hearing health care

Like Eeyore in AA Milne’s Winnie the Pooh stories it appears we all will soon have a personal cloud, but unlike Eeyore this will be something to celebrate! The future of hearing aid technology is in the cloud argues Uwe...

Body self-image – the ENT perspective

Body dysmorphic disorder is a serious psychiatric condition that we all need to be aware of when contemplating aesthetic surgery. It can present in children as well as adults. Prof Vieira and Dr de Carvalho discuss the tell-tale signs and...

A legendary ‘parotid adenoma’: teaching aid or trophy? & The stapes: a classical heresy

A legendary ‘parotid adenoma’: teaching aid or trophy? A wander through the glass cases of the newly refurbished Hunterian Museum at the Royal College of Surgeons in London presents a particularly impressive sight to any ENT surgeon. The salivary adenoma...

Developing medical devices for children: opportunities and challenges

The development of medical devices for infants and children lags significantly behind the development of devices for adults. While in the United States the Food and Drug Administration (FDA) has set up incentives for developing child age-specific pharmaceuticals, there is...

Harnessing head and neck cancer genomics for personalised medicine

Luc Morris updates us on the future of cancer diagnosis and treatment, which lies in “personalised oncology”, where specific molecular alterations of each tumour will be identified, and matched with actionable alterations in existing therapies, ushering in the era of...